The Global Parkinson's Disease Genetics (GP2) Genome Browser
Fang, Z.-H.; Grant, R. H.; Vitale, D.; Hernandez, C. F.; Hong, S.; Leonard, H. L.; Makarious, M. B.; Lange, L. M.; Solomonson, M.; Heutink, P.; Dilliott, A. A.; Galvelis, K. G.; Nalls, M. A.; Singleton, A. B.; Blauwendraat, C.; Global Parkinson's Genetics Program (GP2),
Show abstract
BackgroundLarge-scale sequencing initiatives have generated extensive genomic resources essential for variant interpretation, yet their effective use often requires bioinformatics expertise. To support identification of Parkinsons disease (PD) risk and disease-causing variants, we developed an open-access, summary-level genomic data browser. MethodsWe performed uniform joint variant calling to harmonize whole-genome sequencing (WGS) data from AMP-PD Release 4, GP2 Data Releases, and additional controls from the Alzheimers Disease Sequencing Project. Clinical exome sequencing (CES) data from GP2 Release 8 was also included. ResultsThe integrated dataset includes 31,665 WGS and 9,559 CES samples, spanning eleven ancestries and over 300 million variants. ConclusionThe GP2 Genome Browser is a lightweight, flexible platform providing intuitive gene- and variant-level summaries with ancestry-stratified allele frequencies and functional annotations. It is open source and freely accessible at https://gp2.broadinstitute.org, enabling broad access to PD genomic data and supporting global research efforts.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Evaluating the performance of polygenic risk profiling across diverse ancestry populations in Parkinson’s disease 97%
- Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease 96%
- Parkinson’s Families Project: a UK-wide study of early onset and familial Parkinson’s disease 96%
Similar papers in this journal
- STRchive: a dynamic resource detailing population-level and locus-specific insights at tandem repeat disease loci 90%
- A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer 90%
- MetaRNN: Differentiating Rare Pathogenic and Rare Benign Missense SNVs and InDels Using Deep Learning 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.